Effectiveness, Safety, and Patient Satisfaction of Liraglutide in Type 2 Diabetic Patients

Background and Objectives Liraglutide, an analog of human glucagon-like peptide 1 (GLP-1), has been approved for the treatment of type 2 diabetes mellitus in Pakistan since 2016. It is a GLP-1 receptor agonist that has shown promising results in terms of not only glycemic control but also weight los...

Descripción completa

Detalles Bibliográficos
Autores principales: Zameer, Rafia, Kamin, Matiullah, Raja, Umar, Wahab, Muhammad Umar, Ishtiaq, Osama, Raashid, Kashif, Ahmed, Naveed, Rehman, Asim.ur.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449611/
https://www.ncbi.nlm.nih.gov/pubmed/32864274
http://dx.doi.org/10.7759/cureus.9937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449611/
https://www.ncbi.nlm.nih.gov/pubmed/32864274
http://dx.doi.org/10.7759/cureus.9937

Ejemplares similares